886 results on '"Sun, Aining"'
Search Results
152. Efficacy of Long-Term Decitabine Treatment Combined with Sequential Priming Regimen for Acute Myelocytic Leukemia
153. Trial Test of Sorafenib Alone or in Combination with Chemotherapy for Treating Refractory and Relapsed Acute Myeloid Leukemia with FLT3 Mutation
154. Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria
155. Decitabine As Induction Therapy For Median-To-High-Risk Myelodysplastic Syndromes(MDS) and Acute Myeloid Leukemia(AML) Before Allogeneic Stem Cell Transplantation
156. Clinical Significance Of Circulating Microparticles In Ph- Myeloproliferative Neoplasms (MPN)
157. Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia
158. TIM-3 Is Highly Expressed On Blast Cells In Patients With Acute Myeloid Leukemia
159. The Classical and Alternative NF-κB Activity Supports Cell Survival and Confers Chemo-Sensitivity Of Chronic Lymphocytic Leukemia Cells
160. High Plasma Level Of Regenerating Islet-Derived 3-Alpha (Reg3a) Protein Predicts Grade 3-4 Lower Gastrointestinal Acute Graft-Versus-Host Disease and Poor Prognosis
161. A Novel Therapy Of HLA-Mismatched Sibling Donor Combined With Third-Party Single Cord Blood Cell Transplantation In Patients With Hematologic MalignanciesÂFimproved Outcome Compared To Conventional Transplantation
162. The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity
163. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow
164. Analysis of prognostic factors for survival in 75 Chinese patients with peripheral T-cell lymphoma
165. Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients
166. RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia
167. EZH2 Mutations Are Related to Low Blast Percentage in Bone Marrow and -7/del(7q) in De Novo Acute Myeloid Leukemia
168. A BCR–JAK2 fusion gene from ins(22;9)(q11;p13p24) in a patient with atypical chronic myeloid leukemia
169. Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
170. Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
171. Extramedullary Relapse of Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation —Single Center Experience
172. EZH2 Mutations Are Associated with Low Blast Percentage in Bone Marrow and −7/Del(7q) Karyotype in De Novo Acute Myeloid Leukemia.
173. Long-Term Follow-up Results Over 7 Years for Survival, and Safety with Imatinib Mesylate Accompany with Allogeneic Transplantation for Chronic Myeloid Leukemia
174. Changes of ADAMTS13 Activity and VWF Level in the Plasma of Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
175. Hematopoietic Stem Cell Transplantation (HSCT) Benefits the Survival of Acute Myeloid Leukemia (AML) Patients with IDH1, NRAS and DNMT3A Mutations
176. Analysis of Prognostic Factors for Survival in 75 Chinese Patients with Peripheral T-Cell Lymphoma (PTCL)
177. Impact of Disease Status On Outcomes of Allogeneic Hematopietic Stem Cell Transplantation for Refractory Acute Myeloid Leukemia
178. The Proteasomal Inhibitor Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity.
179. TET2, ANPM1 and FLT3-ITD Gene Mutations in Normal Karyotype Acute Myeloid Leukemia
180. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure
181. Umbilical Cord-Derived Mesenchymal Stem Cells for Treatment of Steroid-Resistant Severe Acute Graft-Versus-Host Disease
182. The Involvement of NF-κB Subunits in the Interaction Between CLL-B Cells and Bone Marrow Stromal Cells
183. Multi-Course of Moderate Dose Cytosine Arabinoside and Fludarabin in the Consolidation Therapy of Patients with De Novo Acute Myeloid Leukemia
184. Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Study of 12 Cases
185. The Effect of KIRs Expression Profile in Donor/Recipient Pairs in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation,
186. Quantitative Assessment of WT1 Gene Transcript After Hematopoietic Stem Cell Transplantation Is a Powerful MRD Marker to Predict the Clinical Outcome in Acute Leukemia
187. A Clinical Study on Double-Unit Umbilical Cord Blood Transplantation in Adults with Hematologic Disease
188. Novel Therapy with Interferon-α in Combination with Donor Lymphocyte Infusion for High Risk Acute Leukemia Patients Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
189. Impact of KIR B/X Genotype and Missing KIR Ligands in HLA-Matched Unrelated Donor HSCT
190. The Efficacy and Safety of Recombinant Human Thrombopoietin in Patients with Hematological Malgnancies After Allogeneic Hematopoietic Stem Cell Transplantation
191. Risk Factors and Clinical Outcome of Thrombotic and Bleeding Complications in 527 Patients Following Hematopoietic Stem-Cell Transplantation (HSCT)
192. Genetic Variations inCD14Promoter and Acute Lymphoblastic Leukemia Susceptibility in a Chinese Population
193. Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity
194. Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant
195. Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21)
196. Clioquinol Arrests Cell Cycle at G1 Phase and Triggers Intrinsic Apoptosis In Myeloma and Leukemia Cells by Inhibiting Histone Deacetylases
197. Minimal Residual Disease Status at Day +100 Post Allogeneic Hematopoietic Stem Cell Transplantation Is a Powerful Predictor for Post-Transplant Outcome In Patients with High Risk Acute Leukemia
198. Clinical, Biological Profile and Outcome of Biphenotypic Acute Leukemia: a Case Series.
199. Identification of JAK1 Mutation In 40 Cases of Adult Acute T Lymphoblastic Leukemia
200. The Effect of KIR B/X Genotype and Missing KIR Ligands In Haploidentical Hematopoietic Stem Cell Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.